|
⚲
|
| Keyboard |
| John Diekman | |
|---|---|
| Firm | |
| Address | c/o IDEAYA Biosciences, Inc 7000 Shoreline Court, Suite 350 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| IDEAYA Biosciences Inc | 021-312153 | Director | 94.0 M of 94.0 M |
||
| IDEAYA Biosciences Inc | 021-269627 | Director | 17.4 M of 46.2 M |
||
| Igenica Biotherapeutics Inc | 021-249373 | Director | 2.3 M of 5.0 M |
||
| Igenica Biotherapeutics Inc | 021-241330 | Director | 1.2 M of 4.0 M |
||
| Igenica Biotherapeutics Inc | 021-232823 | Director | 5.1 M of 6.2 M |
||
| Igenica Inc | 021-211523 | Director | 7.0 M of 14.1 M |
||
| Phaserx Inc | 021-208169 | Director | of 1.5 M |
||
| Phaserx Inc | 021-203901 | Director | 1.4 M of 1.4 M |
||
| Phaserx Inc | 021-199468 | Director | 0.5 M of 1.4 M |
||
| Phaserx Inc | 021-188838 | Director | 1.5 M of 3.0 M |
||
| Igenica Inc | 021-185338 | Director | of 0.0 M |
||
| Phaserx Inc | 021-180834 | Director | 1.6 M of 1.6 M |
||
| Igenica Inc | 021-180189 | Director | 20.3 M of 33.3 M |
||
| Igenica Inc | 021-177577 | Director | of 0.0 M |
||
| Phaserx Inc | 021-173428 | Director | 3.6 M of 4.7 M |
||
| Igenica Inc | 021-147477 | Director | of 0.1 M |
||
| Ingenuity Systems Inc | 021-144293 | Director | 15.4 M of 15.4 M |
||
| Igenica Inc | 021-141481 | Director | 16.1 M of 24.1 M |
||
| Phenomix Corp | 021-139427 | Director | 6.0 M of 14.9 M |
||
| Phaserx Inc | 021-115661 | Director | 1.2 M of 1.2 M |
||
| Igenica Inc | 021-125537 | Director | of 0.0 M |
||
| Ambrx Inc | 021-58840 | Director | 10.0 M of 10.0 M |
||
| 5AM Venture Management LLC | |||||
| 5AM Co-Investors IV LP | 021-207407 | Executive Officer | 10.0 M of 10.0 M |
0.3 M | |
| 5AM Ventures IV LP | 021-204687 | Executive Officer | of 240.0 M |
8.7 M | |
| 5AM Co-Investors III LP | 021-136977 | Executive Officer | 5.5 M of 5.5 M |
0.0 M | |
| 5AM Ventures III LP | 021-128190 | Executive Officer | 197.8 M of 197.8 M |
0.0 M | |